DSP Nifty Healthcare Index Fund details, Fund Portfolio, Fund Returns, Peer Comparison, Mutual Fund Guidance @sahifund.com
Table of Contents:
- NFO Open date, Close date
- NFO Investment Strategy
- NFO Basic Details
- NFO Benchmark Index
- Performance Review of Fund Manager
- Should You Invest in this NFO?
- Invest Online
What is the DSP Nifty Healthcare Index Fund Open Date, Close Date?
NFO opens on June 02, 2025
NFO will close on June 16, 2025
Investment Strategy for this NFO?
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
Basic Details
Fund House | DSP Mutual Fund |
Issue Open | 02 June 2025 |
Issue Close | 16 June 2025 |
Type | Open-ended |
Category | Equity: Sectoral-Pharma |
Min. Investment(Rs) | 100 |
Plans | Growth, IDCW |
Lock-in Period | NA |
Exit Load | 0 |
Riskometer | Very High |
Benchmark | NIFTY Healthcare TRI. |
About Benchmark Index for this NFO?
The Nifty Healthcare Index is designed to reflect the behaviour and performance of the Healthcare companies. The Nifty Healthcare Index comprises of maximum of 20 tradable, exchange listed companies. Nifty Healthcare Index is computed using free float market capitalization method, wherein the level of the index reflects the total free float market value of all the stocks in the index relative to particular base market capitalization value.
Nifty Healthcare Index can be used for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.
Index Variant: Nifty Healthcare Total Returns Index.
Portfolio Characteristics
Methodology | Periodic capped free-float |
No. of Constituents | 20 |
Launch Date | November 18, 2020 |
Base Date | April 01, 2005 |
Base Value | 1000 |
Calculation Frequency | Real-Time |
Index Rebalancing | Semi-Annually |
Fund Managers of DSP Nifty Healthcare Index Fund
1) Anil Ghelani
Education: Mr. Ghelani has done B. Com., CFA & CA
Experience: Prior to joining DSP Mutual Fund he has worked with IL&FS, S. R. Batliboi, V. C. Shah & Co.
2) Diipesh Shah
Education: Mr. Shah is a B Com, ACA, Candidate of the CFA Program, CFA Institute USA, Level I Cleared
Experience: Prior to joining DSP Mutual Fund, he has worked with JM Financial, Centrum Broking, IDFC Securities, ICICI Securities and IIFL Capital Pte Ltd Singapore.
AMC
DSP Investment Managers Pvt. Ltd.
Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai – 400069
Website: https://www.dspim.com/
Registrar & Transfer Agent
Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai – 600002
Website: www.camsonline.com
Review for DSP Nifty Healthcare Index Fund @ sahifund.com by Paresh Gordhandas, C.A., Research Analyst
[ A ] Benchmark Performance of NIFTY Healthcare TRI.
Index Returns (%) | QTD | YTD | 1 Year | 5 Years | Since Inception |
Price Return | 2.72 | -6.01 | 17.36 | 20.32 | 14.06 |
Total Return | 2.72 | -5.82 | 18.03 | 21.13 | 15.02 |
Statistics ## | 1 Year | 5 Years | Since Inception |
Std. Deviation * | 16.81 | 16.59 | 18.67 |
Beta (NIFTY 50) | 0.67 | 0.54 | 0.57 |
Correlation (NIFTY 50) | 0.60 | 0.50 | 0.65 |
Fundamentals
P/E | P/B | Dividend Yield |
38.47 | 6.03 | 0.52 |
Top constituents by weightage
Company’s Name | Weight(%) |
Sun Pharmaceutical Industries Ltd. | 21.20 |
Cipla Ltd. | 9.36 |
Max Healthcare Institute Ltd. | 8.76 |
Divi’s Laboratories Ltd. | 8.30 |
Dr. Reddy’s Laboratories Ltd. | 7.75 |
Apollo Hospitals Enterprise Ltd. | 7.57 |
Lupin Ltd. | 5.43 |
Fortis Healthcare Ltd. | 3.83 |
Torrent Pharmaceuticals Ltd. | 3.73 |
Aurobindo Pharma Ltd. | 3.69 |
Note on Benchmark Performance:
India’s healthcare and diagnostics sector is poised for robust growth over the next three years. The healthcare market is projected to reach $320 billion by 2028, driven by increased demand for services, medical tourism, and government initiatives like Ayushman Bharat. The diagnostics industry, valued at $13 billion in 2023, is expected to grow to $25 billion by 2028, with a compound annual growth rate (CAGR) of 14%. Factors contributing to this growth include a rising prevalence of chronic diseases, an aging population, and greater emphasis on preventive healthcare. Government investments in biotechnology and medical infrastructure further bolster sector expansion.
This scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index. The Healthcare index has provided return of 21.13% during last 5 years and return of 18.03% during last one year. Return of last one year is very impressive and tops almost all the sectoral index.
[ B ] Performance Review of the Fund Managers of this NFO
Past Performance of Anil Ghelani
Fund | DSP Nifty 50 Equal Weight Index Fund | It’s Benchmark | DSP Nifty 50 Index Fund | It’s Benchmark |
1 Year | 8.70 | 10.15 | 11.09 | 10.15 |
3 Year | 19.53 | 17.62 | 16.15 | 17.62 |
5 Year | 27.75 | 24.58 | 23.21 | 24.58 |
7 Year | 14.90 | 14.82 | — | — |
10 Year | — | — | — | — |
As on 22-05-2025
Past Performance of Diipesh Shah
Fund | DSP NIFTY 50 Equal Weight ETF | It’s Benchmark | DSP Nifty 50 ETF | It’s Benchmark |
1 Year | 8.89 | 10.15 | 11.27 | 10.15 |
3 Year | 19.70 | 17.62 | 16.34 | 17.62 |
5 Year | — | — | — | — |
7 Year | — | — | — | — |
10 Year | — | — | — | — |
As on 22-05-2025
Note on Fund Managers’ performance
Both the fund managers associated with the scheme are well experienced and qualified persons. However the past performance of the schemes managed by them show mixed trend.
[ C ] Our NFO guidance
The DSP Nifty Healthcare Index Fund aims to replicate or track the Nifty Healthcare Index, investing in the top 20 healthcare companies based on free-float market capitalisation. Notably, India’s healthcare sector accounts for a relatively small share of the country’s total market capitalisation compared to developed and emerging markets. India’s healthcare and diagnostics sector is poised for robust growth over the next three years. The healthcare market is projected to reach $320 billion by 2028, driven by increased demand for services, medical tourism, and government initiatives like Ayushman Bharat. The diagnostics industry, valued at $13 billion in 2023, is expected to grow to $25 billion by 2028, with a compound annual growth rate (CAGR) of 14%. This indicates significant growth potential, supported by expanding healthcare infrastructure, rising insurance penetration, and ongoing medical innovation.
Notably, 52% of the total revenues for companies in the Nifty Healthcare Index are derived from global markets, compared to just 25% for companies in the Nifty 50 Index and the weakness of Indian currency will boost the returns of this index.
The returns generated by the underlying Index in the last one year, five year and since inception are also good.
However, one has to invest with a longer holding period in mind and a small percentage of portfolio.
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Is it good to invest in DSP Nifty Healthcare Index Fund NFO?
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks